Browse studies

Find your next paid study

1 recruiting study matching your filters

A Study of ELA026 in Participants With Relapsed/Refractory (R/R) T/NK Cell Malignancies (TCMs)

This is a Phase 1, two-part, multicenter study to evaluate ELA026 in participants ≥18 years old with relapsed/refractory TCM following any line of prior therap…

T Cell Malignancies

Estimated

~$10 – $8,750

Electra Therapeutics Inc.NCT07465835